Key facts
- This page summarizes 5AM Ventures V, L.P.'s Form 3/A - Amendment filing for Rallybio Corp (RLYB).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 04 Aug 2021, 21:17.
5AM Ventures V, L.P. - 29 Jul 2021 Form 3/A - Amendment Insider Report for Rallybio Corp (RLYB)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- RLYB
- Reported as of
- 29 Jul 2021
- Net transaction value
- $0
- SEC form
- 3/A - Amendment
- Accepted by SEC
- 04 Aug 2021, 21:17:04 UTC
- Original report date
- 29 Jul 2021
- Next SEC filing
- 09 Sep 2021
- Source filing
- View source filing
- Reporting owner signature
- 5AM Ventures V, L.P., By: 5AM Partners V, LLC, its General Partner, By /s/ Scott M. Rocklage, Managing Member
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
5AM Ventures V, L.P. filed Form 3/A - Amendment for Rallybio Corp (RLYB) on 04 Aug 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3/A - Amendment disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RLYB
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 790,714
- Date
- 29 Jul 2021
- Ownership
- footnote
- Footnotes
- F1, F2, F3
RLYB
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,784,626
- Date
- 29 Jul 2021
- Ownership
- footnote
- Footnotes
- F3, F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Consists of 790,714 shares held by 5AM Opportunities I, L.P. ("Opportunities I")
Footnote F2
5AM Opportunities I (GP), LLC is the general partner of Opportunities I and may be deemed to have sole investment and voting power over the shares held by Opportunities I. Each of Andrew Schwab and Dr. Kush Parmar is a Managing Member of 5AM Opportunities I (GP), LLC, and may be deemed to have shared voting and dispositive power over the shares held by Opportunities I. Therefore, each of Andrew Schwab, Dr. Kush Parmar and 5AM Opportunities I (GP), LLC may be deemed to beneficially own the shares held by Opportunities I, and each disclaims beneficial ownership over the shares held by Opportunities I except to the extent of his or its pecuniary interest therein. Dr. Parmar is a director of the issuer and files separate Section 16 reports.
Footnote F3
This Form 3 amendment is being filed to correct the original Form 3 filed on July 29, 2021. The Amount of Securities Beneficially Owned was stated incorrectly on the original Form 3.
Footnote F4
Consists of 2,784,626 shares held by 5AM Ventures V, L.P. ("Ventures V").
Footnote F5
5AM Partners V, LLC is the general partner of Ventures V and may be deemed to have sole investment and voting power over the shares held by Ventures V. Each of Andrew Schwab, Dr. Kush Parmar and Dr. Scott Rocklage is a Managing Member of 5AM Partners V, LLC, and may be deemed to have shared voting and dispositive power over the shares held by Ventures V. Therefore, each of Andrew Schwab, Dr. Kush Parmar, Dr. Scott Rocklage, and 5AM Partners V, LLC may be deemed to beneficially own the shares held by Ventures V, and each disclaims beneficial ownership over the shares held by Ventures V except to the extent of his or its pecuniary interest therein. Dr. Parmar is a director of the issuer and files separate Section 16 reports.